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Background
Serrated polyp (SP) pathophysiology is of great interest, and 
examination of colonic stem cell (SC) differentiation and crypt 
cell proliferation can provide insight into the natural progression 
of SPs. In normal colonic mucosa, SCs can differentiate into 
neuroendocrine cells (NEC) that reside in the crypt-base stem 
cell niche. SCs also produce rapidly proliferating cells located in 
the proliferative compartment in the lower half of the crypt. 
Staining for minichromosome maintenance 2 (MCM2) 
protein, a component of the DNA helicase involved in the 
initiation of DNA replication, is a marker of cellular proliferation 
in all cell cycle phases. Chromogranin (CGA) is a marker of 
differentiated NECs. Using MCM2 and CGA, we examined these 
cell types in SPs: hyperplastic polyps (HP) and sessile serrated 
adenomas (SSA) with and without cytologic dysplasia.
Methods
Immunohistochemistry was performed on 46 paraffin-embedded SPs (11 HPs, 
31 SSAs, 4 SSAs with dysplasia) and sections of normal colon using anti-MCM2 
antibody (Santa-Cruz, Dallas, TX; 1:200 dilution) and CGA (Dako, Carpinteria, 
CA; 1:10 dilution).  Staining positivity and distribution in both SP and adjacent 
normal colonic mucosa was assessed. 
Expected proliferation/differentiation patterns in normal colon: 
o positive nuclear MCM2 staining of the lower portion of the colonic crypt
o positive cytoplasmic CGA staining of scattered cells in the lower portion of 
the colonic crypt
MCM2 demonstrated 3 major categories of staining: 
o expected/normal: staining limited to lower portion of crypt or slightly 
expanded
o focal: non-continuous full crypt staining  
o diffuse: continuous full crypt staining 
CGA demonstrated the following staining patterns: 
o present (individual scattered cells)  
o absent (non-continuous or continuous)
Results
Patterns of MCM2 staining in SPs: 100% of HPs, SSAs, and SSAs with 
dysplasia showed some degree of positive MCM2 staining throughout the 
entire crypt (focal/diffuse  full crypt staining). Diffuse full crypt proliferation 
was seen in 100% of SSAs with dysplasia, 81% of SSAs, and 64% of HPs. 
Surface staining was focal/absent in all polyps. 
Patterns of MCM2 staining in background normal mucosa: When 
present, areas of histologically normal mucosa adjacent to SPs showed 
aberrant, full crypt staining of MCM2 in 100% of SSAs with dysplasia and 58% 
of SSAs. Adjacent normal mucosa of HPs showed the expected/normal pattern. 
Patterns of CGA staining in SPs: HPs and SSAs showed scattered CGA-
positive cells in the lower crypt (>5 cells per crypt base). 100% of SSAs with 
dysplasia and a small subset of SSAs (30%), showed rare to absent CGA 
positive cells.
Results
Graphic and tabular representation of MCM2 and CGA staining patterns in SPs
Conclusions
o Expansion of the proliferation compartment and neuroendocrine cell 
loss are components of SP development and progression.
o HPs and SSAs show a similar proliferative profile. 
o Aberrant cell proliferation cell staining patterns in the normal colonic 
mucosa adjacent to SSAs with dysplasia (and a subset of SSAs) suggest 
that the colonic microenvironment may play a significant role in SP 
progression. 
o Continued exposure/stimulation from a particular microenvironment 
may promote SP formation and predisposition to malignancy. 
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Objectives
Using immunohistochemistry for MCM2 and CGA:
o Examine the proliferative compartment of SPs
o Assess neuroendocrine cell population in SPs
Goal: Identify potential trends in the proliferative and the 
neuroendocrine cell compartments in SP progression compared to 
the background normal mucosa
HPs SSAs SSAs with dysplasia
Table 1. Observed MCM2, CGA staining patterns
Interpretation: SP progression may include extension of the proliferative 
compartment (orange and green), expansion of proliferative changes to 
surrounding normal mucosa (blue), and loss of NECs (purple). 
Diagram1. Observed MCM2 and CGA staining patterns. (Colors correspond 
to categories in Table1; circle size approximates relative proportion within 
given group.)
Figure3. CGA, SSA with dysplasia shows rare to absent CGA positive cells.
Figure2, MCM2. SSA with dysplasia (left) and adjacent normal mucosa (right) 
showing diffuse MCM2 staining. 
Figure1A-C, MCM2. Normal colonic mucosa (A) compared to full crypt staining in 
HP(B) and SSA (C). 
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